Antifungal susceptibility of yeast bloodstream isolates collected during a 10-year period in Austria

被引:12
|
作者
Beyer, Reinhard [1 ]
Spettel, Kathrin [2 ]
Zeller, Iris [2 ]
Lass-Floerl, Cornelia [3 ]
Achleitner, Dagmar [4 ]
Krause, Robert [5 ,6 ]
Apfalter, Petra [7 ]
Buzina, Walter [8 ]
Strauss, Joseph [1 ,9 ]
Gregori, Christa [1 ]
Schueller, Christoph [1 ,9 ]
Willinger, Birgit [2 ]
机构
[1] Univ Nat Resources & Life Sci, Dept Appl Genet & Cell Biol DAGZ, Vienna Boku, Austria
[2] Med Univ Vienna, Dept Lab Med, Div Clin Microbiol, Vienna, Austria
[3] Med Univ Innsbruck, Div Hyg & Med Microbiol HMM, Innsbruck, Austria
[4] Univ Hosp Salzburg SALK, Div Med Microbiol, Salzburg, Austria
[5] Med Univ Graz, Dept Internal Med, Sect Infect Dis & Trop Med, Graz, Austria
[6] BioTechMed Graz, Graz, Austria
[7] Ordensklinikum Linz Elisabethinen, Inst Hyg Microbiol & Trop Med, Linz, Austria
[8] Med Univ Graz, R&D Inst Hyg Microbiol & Environm Med, Graz, Austria
[9] Univ Nat Resources & Life Sci, Dept Appl Genet & Cell Biol DAGZ, Res Platform Bioact Microbial Metabolites BiMM, Vienna, Austria
关键词
antifungal susceptibility; azoles; Candida; echinocandin; CANDIDA SPECIES DISTRIBUTION; SURVEILLANCE; RESISTANCE; IDENTIFICATION; ECHINOCANDINS; EPIDEMIOLOGY; FLUCONAZOLE; INFECTIONS; MECHANISMS; FUNGEMIA;
D O I
10.1111/myc.12892
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Candida-associated infections put a significant burden on western healthcare systems. Development of (multi-)resistant fungi can become untreatable and threaten especially vulnerable target groups, such as the immunocompromised. Objectives We assessed antifungal susceptibility and explored possible influence factors of clinical Candida isolates collected from Austrian hospitals between 2007 and 2016. Methods Thousand three hundred and sixty clinical Candida spp. isolated from blood cultures were subjected to antifungal susceptibility testing (AFST) in a liquid-handling aided continuous microdilution assay. We tested against fluconazole, voriconazole, posaconazole, itraconazole, isavuconazole, anidulafungin, caspofungin and micafungin according to EUCAST with additional recording of growth curves. We performed rigid quality control on each assay via growth curve assessment and included two standard reference strains. Minimal inhibitory concentrations (MIC) were quantified according to EUCAST guideline E.DEF 7.3.1, and susceptibility was evaluated using EUCAST clinical breakpoints. Results The isolate collection consisted of Candida albicans (59%), C. glabrata (19%), C. parapsilosis (9%), C. tropicalis (5%) and C. krusei (3%) and few other Candida species and fungi (5%). During the observed time period, species abundance and antifungal resistance rates remained constant. Multi-resistance was rare and we found no single isolate which was resistant to both azoles and echinocandins. Within the antifungal resistance profile of our strain collection, we observed clusters along species boundaries. Conclusions Over the last decade, the distribution of Candida species and its level of antifungal resistance remained constant in Austria. Our data compare well with other European countries. Principal component analysis of the susceptibility profile of this collection revealed species-specific clusters and substantial intra-species variation, especially for C. glabrata.
引用
收藏
页码:357 / 367
页数:11
相关论文
共 50 条
  • [1] Antifungal Susceptibility of Candida Bloodstream Isolates Collected During a 10-Year Period in Austria
    Willinger, B.
    Beyer, R.
    Spettel, K.
    Lass-Floerl, C.
    Achleitner, D.
    Krause, R.
    Schueller, C.
    [J]. MYCOSES, 2018, 61 : 28 - 28
  • [2] Species distribution and antifungal susceptibility of Candida bloodstream isolates in Kuwait:: a 10-year study
    Mokaddas, Eiman M.
    Al-Sweih, Noura A.
    Khan, Zia U.
    [J]. JOURNAL OF MEDICAL MICROBIOLOGY, 2007, 56 (02) : 255 - 259
  • [3] Antifungal susceptibility patterns of yeast isolates causing bloodstream infections
    Barchiesi, F
    Caggiano, G
    Maracci, M
    Arzeni, D
    Scalise, G
    Montagna, MT
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (02) : 431 - 433
  • [4] Bloodstream Infections in Children With Cancer: Pathogen Distribution and Antimicrobial Susceptibility Patterns Over a 10-Year Period
    Maarbjerg, Sabine F.
    Kiefer, Lotte V.
    Albertsen, Birgitte K.
    Schroder, Henrik
    Wang, Mikala
    [J]. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2022, 44 (01) : E160 - E167
  • [5] A 10-Year Survey of Antifungal Susceptibility of Candidemia Isolates from Intensive Care Unit Patients in Greece
    Dimopoulos, George
    Velegraki, Aristea
    Falagas, Matthew E.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (03) : 1242 - 1244
  • [6] Evolution of Helicobacter pylori susceptibility to antibiotics during a 10-year period in Lithuania
    Kupcinskas, Limas
    Rasmussen, Lone
    Jonaitis, Laimas
    Kiudelis, Gediminas
    Jorgensen, Marianne
    Urbonaviciene, Neringa
    Tamosiunas, Vytas
    Kupcinskas, Juozas
    Miciuleviciene, Jolanta
    Kadusevicius, Edmundas
    Berg, Douglas
    Andersen, Leif P.
    [J]. APMIS, 2013, 121 (05) : 431 - 436
  • [7] Echinocandin Susceptibility Testing of Candida Isolates Collected during a 1-Year Period in Sweden
    Axner-Elings, Marlene
    Botero-Kleiven, Silvia
    Jensen, Rasmus Hare
    Arendrup, Maiken Cavling
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2011, 49 (07) : 2516 - 2521
  • [8] Antifungal susceptibility profiles of bloodstream yeast isolates by sensititre yeastone: a 9-year experience at a large italian teaching hospital
    Giaquinto, A.
    Spanu, T.
    Sanguinetti, M.
    Tumbarello, M.
    Torelli, R.
    de Carolis, E.
    Posteraro, B.
    [J]. MYCOSES, 2015, 58 : 38 - 38
  • [9] Antifungal susceptibility and enzymatic activity of Candida bloodstream isolates
    Ferreira-Paim, K.
    Fonseca, F. M.
    Ferreira, T. B.
    Silva, B. V.
    Silva, L. B.
    Santos, K. C.
    Silva, P. R.
    Andrade, A. A.
    Silva-Vergara, M. L.
    [J]. MYCOSES, 2012, 55 : 242 - 243
  • [10] Bloodstream Yeast Species and In Vitro Antifungal Susceptibility Profiles
    Nimri, Laila F.
    Kaplan, Nasser M.
    Ishag, Rahmat I.
    [J]. CYPRUS JOURNAL OF MEDICAL SCIENCES, 2021, 6 (02): : 117 - 123